Loading clinical trials...
Loading clinical trials...
Single Arm, Exploratory and Open Phase II Clinical Trial of Apatinib Plus Etoposide Capsule as the Therapy of Advanced Small Cell Lung Cancer
Conditions
Interventions
Apatinib and Etoposide Capsule
Locations
1
China
Henan Cancer Hospital
Zhengzhou, Henan, China
Start Date
November 29, 2017
Primary Completion Date
November 1, 2019
Completion Date
November 1, 2021
Last Updated
July 10, 2020
NCT06066138
NCT06305754
NCT07190248
NCT05692635
NCT07485114
NCT04253964
Lead Sponsor
Henan Cancer Hospital
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions